BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

被引:0
|
作者
Del Giudice, Ilaria [1 ]
Bonina, Silvia [1 ]
Marinelli, Marilisa [1 ]
Cafforio, Luciana [1 ]
Raponi, Sara [1 ]
Boldrini, Eloise [1 ]
Bonafede, Alexia [1 ]
Tavolaro, Simona [1 ]
Ilari, Caterina [1 ]
Messina, Monica [2 ]
Chiaretti, Sabina [1 ]
Mauro, Francesca Romana [1 ]
Piciocchi, Alfonso [3 ]
Orlando, Sonia Maria [3 ]
Rigolin, Gian Matteo [4 ]
Cuneo, Antonio [4 ]
Rossi, Davide [5 ]
Gaidano, Gianluca [5 ]
Guarini, Anna [6 ]
Foa, Robin [1 ]
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, I-00185 Rome, Italy
[3] GIMEMA Fdn, GIMEMA Data Ctr, Rome, Italy
[4] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Hematol Sect, I-44100 Ferrara, Italy
[5] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy
[6] Univ Roma La Sapienza, I-00185 Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q
    Garding, Angela
    Bhattacharya, Nupur
    Haebe, Sarah
    Mueller, Frederike
    Weichenhan, Dieter
    Idler, Irina
    Ickstadt, Katja
    Stilgenbauer, Stephan
    Mertens, Daniel
    HAEMATOLOGICA, 2013, 98 (02) : 269 - 273
  • [32] ATM Gene Point Mutation and Frameshift Mutation Are Found In High-Risk, Untreated Chronic Lymphocytic Leukemia Patients with Interstitial Deletion of Chromosome 11q and Uniparental Disomy of Chromosome 11q
    Schichman, Steven A.
    Han, Jennifer H.
    Saldivar, Juan-Sebastian
    Stone, Annjanette
    Winters, Maria
    Carter, Weleetka
    Frederick, Lori
    Viswanatha, David S.
    Zent, Clive S.
    BLOOD, 2010, 116 (21) : 1003 - 1003
  • [33] Deletion 11q Abnormality in Patients with Chronic Lymphocytic Leukemia (CLL) May Not Have Poor Clinical Outcomes and Bulky Disease (clinical and radiological) At Presentation - Clinical Characteristics of (n=172) Previously Untreated Patients with CLL and del11q Cytogenetic Abnormality
    Jain, Preetesh
    Trinh, Long Xuan
    Benjamini, Ohad
    Lerner, Susan
    Wang, Xuemei
    Ferrajoli, Alessandra
    Burger, Jan A.
    Estrov, Zeev
    Wierda, William G.
    Kantarjian, Hagop M.
    O'Brien, Susan
    Abruzzo, Lynne V.
    Keating, Michael J.
    BLOOD, 2012, 120 (21)
  • [34] Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia
    Zou, Yi-Xin
    Tang, Han-Ning
    Zhang, Jing
    Tang, Xiao-Lu
    Qin, Shu-Chao
    Xia, Yi
    Zhu, Hua-Yuan
    Qiao, Chun
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jian-Yong
    Miao, Yi
    TRANSLATIONAL ONCOLOGY, 2021, 14 (10):
  • [35] Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion
    Ding, Wei
    Ferrajoli, Alessandra
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 90 - 92
  • [36] The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia
    Stankovic, Tatjana
    Skowronska, Anna
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1227 - 1239
  • [37] Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion
    Austen, Belinda
    Skowronska, Anna
    Baker, Claire
    Powell, Judith E.
    Gardiner, Anne
    Oscier, David
    Majid, Aneela
    Dyer, Martin
    Siebert, Reiner
    Taylor, A. Malcolm
    Moss, Paul A.
    Stankovic, Tatjana
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5448 - 5457
  • [38] Microarray-CGH screening of copy number aberrations in chronic lymphocytic leukemia with normal karyotype
    Oikarainen, A
    Lundán, T
    Wolf, M
    Elonen, E
    Vilpo, J
    Porkka, K
    Knuutila, S
    ANNALS OF ONCOLOGY, 2005, 16 : 88 - 88
  • [39] Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    Kim, Jongphil
    Yue, Binglin
    Dalia, Samir
    Pinilla-Ibarz, Javier
    Anasetti, Claudio
    Locke, Frederick L.
    LEUKEMIA RESEARCH, 2014, 38 (10) : 1165 - 1172
  • [40] Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment
    Moia, Riccardo
    Diop, Fary
    Favini, Chiara
    Spaccarotella, Elisa
    De Paoli, Lorenzo
    Bruscaggin, Alessio
    Spina, Valeria
    Cerri, Michaela
    Deambrogi, Clara
    Kodipad, Ahad Ahmed
    Favini, Simone
    Sagiraju, Sruthi
    Jabangwe, Clive
    Mauro, Francesca Romana
    Del Giudice, Ilaria
    Forconi, Francesco
    Cortelezzi, Agostino
    Zaja, Francesco
    Visco, Carlo
    Chiarenza, Annalisa
    Rigolin, Gian Matteo
    Marasca, Roberto
    Coscia, Marta
    Perbellini, Omar
    Tedeschi, Alessandra
    Laurenti, Luca
    Motta, Marina
    Del Poeta, Giovanni
    Cuneo, Antonio
    Gattei, Valter
    Foa, Robin
    Gaidano, Gianluca
    Rossi, Davide
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S11 - S12